Hacksell Uli

Average Profitability
11.11%
Insider Buys Quantity
3
Insider Buys Sum
$19,100.00
Insider Sells Quantity
22
Insider Sells Sum
$15.45M

Insider Activity of Hacksell Uli

The largest purchase of all time was on 2016-12-10 and amounted to 10000 shares of Avalo Therapeutics, Inc. for $10,700.

The largest sale of all time was on 2013-08-13 and amounted to 105542 shares of ACADIA Pharmaceuticals Inc. for $2.13M.

Biography of Hacksell Uli

No biography is available at this moment.

2017-06-09PurchaseAvalo Therapeutics, Inc.
AVTX
director
10,000
0.0061%
$0.42$4,200+263.27%
2016-12-10PurchaseAvalo Therapeutics, Inc.
AVTX
director
10,000
0.006%
$1.07$10,700-34.25%
2015-02-17SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
60,000
0.0306%
$17.92$1.08M+5.07%
2015-01-14SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
60,000
0.0319%
$17.99$1.08M+9.02%
2014-12-15SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
60,000
0.0336%
$16.50$989,916+21.31%
2014-11-24SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
60,000
0.0327%
$15.64$938,397+23.81%
2014-10-08SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
60,000
0.0319%
$13.08$784,530+41.74%
2014-09-10SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
60,000
0.0324%
$14.68$880,821+26.18%
2014-08-15SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
30,000
0.0199%
$14.88$446,271+47.54%
2014-07-14SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
40,000
0.0265%
$14.54$581,574+44.68%
2014-06-16SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
40,000
0.0263%
$14.98$599,204+34.4%
2014-04-15SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
50,000
0.034%
$12.35$617,585+46.84%
2014-02-18SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
50,000
0.0343%
$15.55$777,278+4.02%
2014-01-15SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
50,000
0.0347%
$15.48$774,0380%
2013-12-02SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
30,000
0.0164%
$12.73$381,807-5.5%
2013-11-01SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
30,000
0.0181%
$12.62$378,638+2.93%
2013-08-13SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
105,542
0.1181%
$20.14$2.13M+13.99%
2013-05-02SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
40,898
0.0491%
$12.34$504,792+82.36%
2013-05-01SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
39,102
0.0269%
$6.90$269,634+87.06%
2013-04-16SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
33,458
0.0217%
$6.70$224,115+81.36%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.